Serge Belanger
Stock Analyst at Needham
(3.79)
# 613
Out of 4,842 analysts
356
Total ratings
46.08%
Success rate
8.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LQDA Liquidia | Reiterates: Buy | $25 | $14.18 | +76.37% | 31 | May 28, 2025 | |
| ARQT Arcutis Biotherapeutics | Reiterates: Buy | $20 | $13.58 | +47.28% | 21 | May 23, 2025 | |
| VRDN Viridian Therapeutics | Reiterates: Buy | $36 | $13.50 | +166.67% | 17 | May 20, 2025 | |
| TRVI Trevi Therapeutics | Reiterates: Buy | $24 | $6.26 | +283.39% | 21 | May 20, 2025 | |
| OMER Omeros | Reiterates: Hold | n/a | $3.14 | - | 7 | May 16, 2025 | |
| CLSD Clearside Biomedical | Maintains: Buy | $4 → $3 | $0.79 | +281.39% | 15 | May 15, 2025 | |
| VRCA Verrica Pharmaceuticals | Reiterates: Hold | n/a | $0.54 | - | 19 | May 14, 2025 | |
| CYTK Cytokinetics | Reiterates: Buy | $72 | $30.28 | +137.78% | 23 | May 14, 2025 | |
| MLTX MoonLake Immunotherapeutics | Reiterates: Buy | $66 | $38.13 | +73.09% | 13 | May 13, 2025 | |
| XENE Xenon Pharmaceuticals | Maintains: Buy | $60 → $55 | $28.49 | +93.05% | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $30 | $25.54 | +17.46% | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $40 | $17.27 | +131.62% | 8 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $9.30 | +136.56% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $12.43 | +20.68% | 17 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $0.83 | +379.21% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $7.89 | +77.44% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $17 | $10.56 | +60.98% | 13 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.83 | +118.58% | 22 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $25.26 | - | 5 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $28.95 | +58.92% | 25 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $28 | $11.40 | +145.61% | 20 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.88 | - | 1 | Mar 31, 2022 |
Liquidia
May 28, 2025
Reiterates: Buy
Price Target: $25
Current: $14.18
Upside: +76.37%
Arcutis Biotherapeutics
May 23, 2025
Reiterates: Buy
Price Target: $20
Current: $13.58
Upside: +47.28%
Viridian Therapeutics
May 20, 2025
Reiterates: Buy
Price Target: $36
Current: $13.50
Upside: +166.67%
Trevi Therapeutics
May 20, 2025
Reiterates: Buy
Price Target: $24
Current: $6.26
Upside: +283.39%
Omeros
May 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $3.14
Upside: -
Clearside Biomedical
May 15, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $0.79
Upside: +281.39%
Verrica Pharmaceuticals
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.54
Upside: -
Cytokinetics
May 14, 2025
Reiterates: Buy
Price Target: $72
Current: $30.28
Upside: +137.78%
MoonLake Immunotherapeutics
May 13, 2025
Reiterates: Buy
Price Target: $66
Current: $38.13
Upside: +73.09%
Xenon Pharmaceuticals
May 13, 2025
Maintains: Buy
Price Target: $60 → $55
Current: $28.49
Upside: +93.05%
May 9, 2025
Maintains: Buy
Price Target: $32 → $30
Current: $25.54
Upside: +17.46%
May 8, 2025
Maintains: Buy
Price Target: $42 → $40
Current: $17.27
Upside: +131.62%
May 8, 2025
Reiterates: Buy
Price Target: $22
Current: $9.30
Upside: +136.56%
May 7, 2025
Maintains: Buy
Price Target: $12 → $15
Current: $12.43
Upside: +20.68%
May 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $0.83
Upside: +379.21%
May 6, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $7.89
Upside: +77.44%
May 6, 2025
Maintains: Buy
Price Target: $15 → $17
Current: $10.56
Upside: +60.98%
Apr 11, 2025
Reiterates: Buy
Price Target: $4
Current: $1.83
Upside: +118.58%
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $25.26
Upside: -
Apr 9, 2025
Reiterates: Buy
Price Target: $46
Current: $28.95
Upside: +58.92%
Apr 8, 2025
Reiterates: Buy
Price Target: $28
Current: $11.40
Upside: +145.61%
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.88
Upside: -